Current Price Status
Stock in Weak Growth Expectation
Stock is currently in distressed situation that the market is pricing a worse than industry average negative annual earning growth.
Stock in this situation can be good bargain if the stock beats the weak growth expectation or it can be long-term downtrend if the weak earning growth remains for a while.
Company is in Positive Earning
- PHARMA current price is 32.54% below OneDelta estimated fair value.
The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.
Relative Price Performance
UnderperformedPHARMA past 5-day return lagged behind the Pharmaceuticals industry average return by 3.21%
Below 30-Day AverageCurrent price RM0.845 is below 30-day average RM2.95 by 249.1%
Bank Analyst Price Targets
Revenue & Earning Growth Analysis
Cyclical Revenue Growth
PHARMA recorded various revenue growth in different quarters with no clear growth direction.
Unstable Profit Growth
PHARMA has been experiencing substantial ups and downs on profit growth.
Past Quarter Reports
|Quarter Date||Revenue (RM)||(%)||EPS (RM)||(%)|
Volume Trend Analysis
Recent Volume is Increasing
Surge in trading volume tends to bring more price volatility in near term.
PHARMA recent daily traded volume is 1.94% higher than past month average.
|Past 30-Day||Past 5-Day|
|103k daily||105k daily|
Price History Chart
Past 30-day Average Price: RM2.95
Stock Fundamental Factors
Fundamental factor characteristics help us understand and expect how the stock price will behave in short and long term.
Market News & Investor Opinions
Stock Company Profile
Pharmaniaga Bhd. is an investment holding company. It engages in the research & development, manufacturing of generic pharmaceutical products, sales & marketing as well as logistics and distribution of pharmaceutical products & medical equipment. The firm operates through the following segments: Logistics and Distribution, Manufacturing, and Indonesia. The Logistics and Distribution segment engages in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia. The Manufacturing segment manufactures pharmaceutical products in Malaysia. The Indonesia segment manufactures and distributes pharmaceutical and medical products in Indonesia. The company was founded on August 21, 1998 and is headquartered in Shah Alam, Malaysia.